Business
Director's Shareholding Updat
Director's Shareholding Updat.
About this update from Genedrive Plc
[{"type":"text","content":"\n RNS Number : 4665J Epistem Holdings plc 01 April 2010 \n\nFor release: 1 April 2010\n \nEpistem Holdings Plc (\"Epistem\" or the \"Company\")\n \nDirectors' Shareholdings\n \nEpistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.\n \nAs a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors have each increased their beneficial interest in the Company by 249 ordinary shares of 1.5p each. These shares were acquired in tranches at the end of January, February and March 2010 at prices of 445p, 442p and 447p respectively.\n \nThe current beneficial interests of the executive Directors are set out below:\n \n \nMatthew Walls 6,901 (0.08%)\nDr Catherine Booth 981,256 (12.37%)\nDr Ged Brady 1,256 (0.02%)\nDr Jeffrey Moore 15,756 (0.20%) \nJohn Rylands &...